Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Nov 28;62(1):209–227. doi: 10.1111/bjc.12404

The effectiveness of third wave cognitive behavioural therapies for children and adolescents: A systematic review and meta‐analysis

Amorette M Perkins 1,2, Richard Meiser‐Stedman 1,, Samuel W Spaul 2, Gemma Bowers 2, Abigail G Perkins 1, Laura Pass 1,
PMCID: PMC10100516  PMID: 36443910

Abstract

Objectives

Third wave cognitive behavioural therapies are increasingly used with children and adolescents. This meta‐analysis aimed to determine the effectiveness of four third‐wave interventions (acceptance and commitment therapy, compassion focused therapy, mindfulness‐based cognitive therapy, and metacognitive therapy) for youth.

Methods

Four electronic databases were used to identify randomized controlled trials, which tested effects related to health, well‐being and functioning. Sensitivity analyses considering study quality were conducted and moderators were explored.

Results

The results based on 50 RCTs meeting inclusion criteria indicated emotional symptoms/internalizing problems (g = −.68, 95% CI −.98 to −.37, k = 43, N = 3265), behavioural difficulties/externalizing problems (g = −.62, 95% CI −1.01 to −.22, k = 23, N = 1659), interference from difficulties (g = −.46, 95% CI −.87 to −.05, k = 21, N = 1786), third wave processes (g = .39, 95% CI .17 to .62, k = 22, N = 1900), wellbeing/flourishing (g = .76, 95% CI .35 to 1.17, k = 21, N = 1303) and physical health/pain (g = .72, 95% CI .01 to 1.44, k = 9, N = 1171) yielded significant effects. Effect for quality of life (g = .62, 95% CI −.08 to 1.31, k = 12, N = 1271) was non‐significant. When analysing only those studies rated moderate‐high quality, third wave interventions yielded significant superiority effects compared to controls for emotional symptoms/internalizing problems (g = −.55, 95% CI −.82 to −.27, k = 28, N = 2110), interference from difficulties (g = −.48, 95% CI −.90 to −.05, k = 21, N = 1605), third wave processes (g = .27, 95% CI .11 to .43, k = 18, N = 1692), well‐being/flourishing (g = .50, 95% CI .18 to .81, k = 16, N = 1063), and quality of life (g = .32, 95% CI .04 to .60, k = 10, N = 1212). Behavioural difficulties/externalizing problems (g = −.38, 95% CI −.86 to .10, k = 15, N = 1351) and physical health/pain (g = .52, 95% CI −.14 to 1.17, k = 8, N = 1139) ceased to be significant. Widespread heterogeneity raised concerns about generalizability and follow‐up data was relatively sparse.

Conclusions

This meta‐analysis finds promising results for use of third wave CBT with youth, though the review has limitations.

Keywords: adolescent mental health, child mental health, meta‐analysis, third wave cognitive behavioural therapy


Practitioner points.

  • This review considers the effectiveness of four types of third wave CBT as a transdiagnostic approach for children and adolescents.

  • When low quality studies were excluded, results indicated promising effects for a variety of outcomes related to psychological symptoms, well‐being and functioning.

  • The evidence in this review was limited by considerable heterogeneity, with moderation and subgroup analyses offering limited explanation and restricted by current availability of research.

  • Significant effects for emotional symptoms/internalizing problems were maintained at follow‐up, however analyses suggested no long‐term benefits for other outcomes. There were nonetheless limitations to follow‐up analyses that need to be addressed.

INTRODUCTION

The term “third wave cognitive behavioural therapy (CBT)” refers to a group of psychological interventions that have been developed out of the existing cognitive behavioural interventions over recent decades (Brown et al., 2011). Many third wave methods are argued to offer a transdiagnostic approach, targeting common psychological processes relevant across the continuum from ill‐health to flourishing, rather than specific models of disorder or disease (Hayes & Hofmann, 2017). Interventions that could be universally applied to improve youth mental health and well‐being, offering continuity across levels of public health, are of particular interest given rising mental health issues amongst children and adolescents (Public Health England [PHE], 2019; UK Department of Health [DoH] & Department for Education [DfE], 2017).

Third wave therapies have thus gained increasing attention for use in younger populations, being implemented across presentations related to physical health, mental health, and substance use, as well as within neurodiverse groups and those at social disadvantage including children in care (e.g. Kallesoe et al., 2021; Kashefinishabouri et al., 2021; Makki et al., 2018; Pahnke et al., 2014; Thurstone et al., 2017; Wicksell et al., 2009). Third wave interventions have been delivered in clinics, schools, communities and via online platforms across the spectrum from treatment and prevention of ill‐health to the promotion of wellbeing and flourishing (e.g. Burckhardt et al., 2016; Syeda & Andrews, 2021; Twohig et al., 2021; White et al., 2022). Despite its widespread use, the effectiveness of third wave CBT as a transdiagnostic approach remains unclear, with no known meta‐analysis to synthesize existing data across child and youth populations to estimate effectiveness for a variety of presentations and outcomes.

Several therapies have been classified under the umbrella term of “third wave” approaches (O'Brien et al., 2008). The current article focused on four of the most recently developed third wave therapies; each using transdiagnostic cognitive and behavioural techniques with relevance along the continuum of ill‐health to flourishing. These were acceptance and commitment therapy (ACT; Hayes et al., 1999), compassion focused therapy (CFT; Gilbert, 2010), mindfulness‐based cognitive therapy (MBCT; Segal et al., 2002) and metacognitive therapy (MCT; Wells, 2009). These four therapies have many common methods and processes, including meta‐cognition, mindfulness, acceptance, decentering, self‐compassion, values‐focused behaviour, and perspective taking (Brown et al., 2011; Neff & Tirch, 2013).

The primary aim of this review was to use a meta‐analytic approach to determine the effectiveness of these four third wave interventions for children and adolescents for the following outcomes: (1) emotional symptoms/internalizing problems, (2) behavioural difficulties/externalizing problems, (3) interference from (emotional or physical) difficulties, (4) third wave processes (e.g. acceptance/mindfulness/self‐compassion), (5) well‐being/flourishing, (6) quality of life and (7) physical health/pain. The impact of study quality was also assessed. Secondary aims were to: (1) explore variation in effectiveness amongst types of third wave CBT, settings, populations, control conditions and formats of delivery (e.g. group versus individual therapy); (2) estimate effect sizes at follow‐up; and (3) compare third wave CBT to other psychological therapies. In keeping analyses comprehensive and broad, the review aimed to provide an initial, sweeping overview and synthesis of current data to inform future practice and research.

METHOD

A protocol for this review was preregistered with PROSPERO (ID REMOVED FOR BLINDING).

Literature search

PsycINFO, PubMed, Scopus and the Cochrane CENTRAL Trials Register were searched from inception to April 8th 2022 (initial searches were conducted in April 2019 before being updated in November 2019 then again in April 2022). The search strategy was: (“acceptance and commitment therapy” OR “compassion focus* therapy” OR “compassionate mind training” OR “mindfulness based cognitive therapy” OR “metacognitive therapy”) OR ([“third wave” OR “new wave”] AND therap*) AND (“child*” OR “adolescen*” OR “teen*” OR “parent*” OR “school” OR “youth*” OR “young people”). The first 200 results of both Google Scholar and a university library database were also searched.

Inclusion criteria comprised the following: (1) primary empirical studies that used a randomized controlled design (individual or cluster randomization); (2) investigating ACT, CFT, MBCT or MCT compared to a control group (which could be: no intervention, waitlist, or treatment as usual/an active intervention, as long as it was not one of the included third wave therapies); (3) with at least one outcome measure for children and adolescents under 18 years old; (4) that offered sufficient data in the paper (or by contacting authors) to calculate effect sizes required for meta‐analysis, of at least one outcome measure; and (5) were reported in an English language within a peer‐reviewed journal.

This review included studies conducted in any setting (e.g. schools, general hospitals or mental health clinics), using any measure related to the seven primary outcome domains (emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, interference from difficulties, third wave processes, wellbeing/flourishing, quality of life, and physical health/pain). The outcomes studied were intentionally broad given that the chosen forms of third wave CBT were promoted as transdiagnostic and relevant to thriving as well as pathology (Hayes & Hofmann, 2017).

Diagnosis/presentation or mode of delivery (e.g. face‐to‐face, online, telephone) did not serve as exclusion criteria. Interventions were included whether they were delivered to children and/or via parents/carers/significant others, as long as the child was the reason for accessing the intervention and there was a child‐focused outcome measure. In line with the protocol, non‐standardized interventions drawing on the four included therapies or combining other approaches were included, and accounted for within the quality assessment, to represent that many have attempt to implement third wave approaches to child populations in varying ways (Hayes & Ciarrochi, 2015).

Eligible studies

The initial search produced 1778 results, plus there were an additional 400 records from alternative sources. Updated searches yielded a further 896 results. With duplicates removed, there were a total of 1808 records. The first author (AMP) screened titles and abstracts for eligibility. Full‐text articles of 334 potentially eligible studies were retrieved and further examined against inclusion and exclusion criteria by two authors (AMP, SWS). Any uncertainties regarding eligibility were resolved by discussion with a second or third reviewer (AGP, LP). Fifty‐six papers met inclusion criteria, describing 50 studies (Figure 1).

FIGURE 1.

FIGURE 1

Diagram adapted from PRISMA, detailing flow of studies retrieved from searches through to inclusion.

Data extraction

Two authors (AMP, SWS) extracted demographic and methodological data. Data for meta‐analyses were also extracted following pre‐determined rules: (1) post‐intervention data were used in the primary analyses; (2) where there were multiple measures within a trial for a single outcome, the mean of effect sizes for all relevant measures was calculated and inputted into the meta‐analyses; (3) follow‐up data were extracted separately to post‐intervention data ‐ if multiple follow‐ups were completed, the furthest time point was chosen; (4) if there were multiple comparison groups, a non‐active control was chosen for the primary analyses in the first instance, followed by a non‐psychological then psychological intervention, given the primary research aim was to determine the effectiveness of third wave CBT not to compare it to other interventions (a separate, additional pool of data was extracted for secondary analyses comparing third wave CBT to other established psychological interventions); (5) data from intention‐to‐treat samples were included in analyses as preference, followed by data from subsets (e.g. assessment/treatment completers). All extraction of study characteristics and data for meta‐analyses were verified by a second reviewer.

Quality assessment

Study quality was assessed using the Cochrane risk‐of‐bias tool for randomized trials (Sterne et al., 2019; Version 2), supplemented with items adapted from the NICE quality appraisal checklist for quantitative intervention studies (NICE, 2012). These additional items focused on quality of reporting, sampling (including generalizability and power), and the specificity (i.e. whether third wave CBT was distinct rather than combined with non‐relevant interventions, as described in inclusion criteria) and quality of the intervention (i.e. whether third wave CBT was manualized, comprehensive, developmentally adapted). The Cochrane tool for cluster‐randomized designs was used where appropriate (Eldridge et al., 2016). All papers were assigned quality ratings by two independent reviewers (AMP, SWS, AGP). The reviewers worked together if there were any ambiguities or discrepancies, to assign an agreed overall categorical rating of either low, moderate or high quality.

See Appendix S1 for the final quality ratings assigned to each study, and Appendix S2 for the quality assessment tool.

Data analysis

Separate meta‐analyses were conducted to estimate effect sizes of third wave CBT at post‐intervention for each of the seven primary outcomes. The outcome categories were decided collaboratively by the research team prior to data extraction, based on clinical knowledge and literature (see Appendix S3). The impact of including low quality studies was assessed with sensitivity analyses. Secondary analyses were conducted to explore moderators, which included: (1) type of third wave CBT (ACT versus MBCT only, due to insufficient comparators for the other therapies); (2) setting (clinical [physical or mental health settings] versus non‐clinical [i.e. school or community, e.g. summer camps]); (3) type of control condition (active versus inactive); (4) participant age group (child versus adolescent); (5) delivery format (group versus individual therapy); and (6) parental involvement (child‐only versus joint/parent sessions). To correct for multiple comparisons within each meta‐analysis, the Holm‐Bonferroni method was used across moderators and subgroup analyses (Holm, 1979). Secondary analyses were also used to investigate effects at follow‐up and studies comparing third wave CBT to other psychological therapies.

Analyses were conducted using meta‐analysis via Shiny, which applies R programming language (MAVIS Version 1.1.3; Hamilton et al., 2017). Between‐group effect sizes were entered into random‐effects models to account for heterogeneity. MAVIS uses the metafor package (Viechtbauer, 2010) in R to calculate a standardized mean difference, which is converted to a Hedge's g (1981). Effect sizes of .2, .5 and .8 were interpreted as small, moderate and large, respectively (Fritz et al., 2012). The direction of effect which favoured third wave CBT was determined by the relative positivity or negativity of the scales which captured each outcome variable: for emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems and interference from difficulties, a negative effect size favoured the intervention group whilst a positive effect size favoured the control comparison, whilst for third wave processes, wellbeing/flourishing, quality of life, and physical health/pain, a positive effect size favoured the intervention group whilst a negative effect favoured the control comparison.

I 2 was used to estimate the percentage of heterogeneity between studies that were not attributable to random sample error alone; values of 0%, 25%, 50% and 75% reflected nil, low, moderate and high levels of heterogeneity, respectively. Heterogeneity was also examined using the Q‐statistic; if significant (p < .05), it indicated that heterogeneity exceeded that expected by chance alone. Heterogeneity was subsequently explored using moderation and subgroup analyses. Moderation was tested using the Qb statistic, which is the level of variation explained by a covariate. Subgroup analyses were important to interpret any significant moderation effects, to address clinically important questions around what particular forms of third wave CBT might be effective, for whom, and in what settings. Subgroup analyses were still conducted when moderation was non‐significant, as high levels of heterogeneity within each subgroup could have led to a non‐significant moderation effect, even when subgroups vastly differed with regards to average effect size. To maintain reliability, moderation and subgroup analyses were not conducted if there were fewer than four studies per group.

Further sensitivity analyses excluded studies which used cluster randomization techniques. Funnel plots were created and publication bias was assessed in two steps. First, rank correlation tests for asymmetry were performed; a high and significant correlation (p < .05) indicated that the funnel plot was asymmetric and thus there was potential for bias. Second, visual inspection and trim‐and‐fill methods were used to estimate whether there were any missing studies that account for significant asymmetric distribution (Higgins & Green, 2011).

RESULTS

Sample size and characteristics

Fifty studies were included, comprising 4476 participants. Sample sizes ranged from 11–586, with a median of 50.5 (IQR 35.25–89.75). Studies were published between 2006 and 2022. Thirty‐three investigated ACT, 13 investigated MBCT, two investigated CFT approaches, one investigated MCT, and one investigated ACT combined with CFT. Twenty‐two studies utilized an inactive control group (no intervention/waitlist), 18 an active control group (namely treatment as usual or other interventions), and 10 made multiple comparisons (seven compared to both an inactive and active control group, and three compared to two different active conditions). Intervention duration ranged from a single, 30‐min session to 50 h of therapy over 20 weeks. Thirty‐four studies were group interventions, 14 comprised individual therapy, and two did not report delivery format. Thirty‐three delivered the intervention directly with the child/adolescent, eight with parent/carers only, and nine with both the parent/carer and young person.

Interventions were delivered in schools or communities (33), clinical physical health settings (11), and clinical mental health settings (6). Studies were conducted across various countries, including: Iran (17), Australia (8), Sweden (5), China (4), USA (4), Belgium (3), Finland (1), Denmark (1), Italy (1), Cyprus (1), Germany (1), Canada (1), India (1), Colombia (1) and the Philippines (1). Populations or conditions studied were related to: physical health (12), anxiety/stress (9), depression (4), family/care situations (4), behavioural difficulties (3), learning/neurodevelopmental difficulties (2), social/school difficulties (2), trichotillomania (2), eating/body image disorders (2), low wellbeing (1), and mixed internalizing and/or externalizing difficulties (2). The remaining studies (7) were conducted with general samples (e.g. exploring interventions as preventative or promotive wellbeing strategies). The age of participants ranged from 0–18 (M = 12.92, SD = 3.27); although, these statistics do not include nine studies in which average age was unreported. Twenty‐three studies collected follow‐up data in addition to post‐intervention effects, with three studies excluded from analysis at this point due to no longer meeting inclusion criteria; follow‐up length ranged from 1–24 months (Mdn = 3.5, IQR 2–6).

Appendix S1 further details the characteristics of included studies.

Study quality and attrition

Ten studies were rated as high quality, 22 moderate quality, and 18 low quality. Twelve studies were rated highly with regards to quality of the intervention (Appendix S1). Eleven studies did not report sample attrition at post‐treatment; of those that did, dropout rates ranged from 0–61.54%, with a median of 9.64% (IQR 4.33–19.07). Median attrition at furthest follow‐up was 20.29% (IQR 14.95–38.69); though this excludes four studies that did not report dropout. Sixteen studies did not specify whether data represented all participants randomized at outset or only a subset (e.g. assessment/treatment completers); for these papers, it was assumed that data represented the completer sample for each time point. Eight studies specified using a completer sample. For 20 studies, it was reported that intention‐to‐treat methods were applied (at least partially or in some form to include all participants randomized). In six studies, there was no attrition and thus a complete sample.

Primary analyses

Main effects for the primary outcomes at post‐intervention are presented in Table 1. Twenty‐nine studies at post‐intervention compared to inactive controls while the remainder used active conditions (see Table 1 for a breakdown per outcome). These active comparisons included: other psychological interventions (5), broad “treatments as usual”, such as multi‐disciplinary care (5), school pastoral/counsellor/nurse support (4), educational/activity‐based groups (4), medication/medical care (2) and the usual school curriculum (1). Overall, significant and small sized effects were found favouring third wave CBT for interference from difficulties and third wave processes. Significant medium‐sized superiority effects were found for emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, wellbeing/flourishing, and physical health/pain. A non‐significant effect was only observed for quality of life. For all variables, there was significant heterogeneity (I 2 ranged from 79%–97%).

TABLE 1.

Main effects for the primary outcome variables

k g a 95% CI p‐value Heterogeneity I 2 (Q with p‐value)
Emotional symptoms and internalizing problems (A = 19, I = 24)
Overall effect (N = 3265) 43 −.68 −.98 to −.37 <.001 94% (435.30, <.001)
Excluding low quality studies (N = 2110) 28 −.55 −.82 to −.27 <.001 88% (132.78, <.001)
Behavioural difficulties and externalizing problems (A = 9, I = 14)
Overall effect (N = 1659) 23 −.62 −1.01 to −.22 .002 93% (168.12, <.001)
Excluding low quality studies (N = 1351) 15 −.38 −.86 to .10 .119 94% (107.48, <.001)
Interference from difficulties (A = 13, I = 8)
Overall effect (N = 1786) 21 −.46 −.87 to −.05 .028 93% (267.99, <.001)
Excluding low quality studies (N = 1605) 17 −.48 −.90 to −.05 .027 93% (213.17, <.001)
Third wave processes (A = 11, I = 11)
Overall effect (N = 1900) 22 .39 .17 to .62 <.001 79% (79.20, <.001)
Excluding low quality studies (N = 1692) 18 .27 .11 to .43 <.001 51% (33.90, .009)
Wellbeing and flourishing (A = 8, I = 13)
Overall effect (N = 1303) 21 .76 .35 to 1.17 <.001 92% (146.42, <.001)
Excluding low quality studies (N = 1063) 16 .50 .18 to .81 .002 82% (66.56, <.001)
Quality of life (A = 5, I = 7)
Overall effect (N = 1271) 12 .62 −.08 to 1.31 .082 97% (84.89, <.001)
Excluding low quality studies (N = 1212) 10 .32 .04 to .60 .024 77% (34.83, <.001)
Physical health and pain (A = 5, I = 4)
Overall effect (N = 1171) 9 .72 .01 to 1.44 .047 96% (163.38, <.001)
Excluding low quality studies (N = 1139) .52 −.14 to 1.17 .122 96% (141.38, <.001)

Abbreviations: A, number of active controls in the main analysis for overall effect; CI, confidence interval; I, number of inactive controls in the main analysis for overall effect; I 2, percentage heterogeneity; k, number of studies; g, Hedges' g; N, participants included in analysis (based on intention‐to‐treat sample where available); Qb, Qb‐statistic or level of variation explained by a covariate.

a

For emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, and interference from difficulties, a negative effect size favours the intervention group whilst a positive effect size favours the control comparison. For the remaining outcomes (third wave processes, well‐being/flourishing, quality of life and physical health/pain), a positive effect size favours the intervention group whilst a negative effect favours the control comparison.

Significant effect sizes (p < .05) are denoted in bold.

Impact of study quality

Sensitivity analyses excluding low quality studies were performed and are presented alongside main effects in Table 1. Results indicated that study quality had a substantial impact for some outcome variables. Behavioural difficulties/externalizing problems and physical health/pain ceased to be significant. Quality of life now yielded a small significant effect. Emotional symptoms/internalizing problems and wellbeing/flourishing remained significant with a moderate effect size, whilst interference from difficulties and third wave processes remained significant with small effect sizes.

Figure 2 depicts forest plots for the primary analyses.

FIGURE 2.

FIGURE 2

Forest plots detailing effect sizes with 95% confidence intervals for the seven primary outcome variables, inclusive and exclusive of low quality studies.

Secondary analyses

Moderation and subgroup analyses

Moderation with subgroup analyses are presented to aid interpretation of heterogeneity (Table 2). However, these should be interpreted with caution as studies rated as low quality were included to maintain number of available comparators. There remained too few comparators for some moderator analyses (<4 per subgroup) as indicated on Table 2. All studies included in analyses for physical health/pain used ACT interventions. No significant moderators were found for any of the seven primary outcomes, with the exception of control condition for emotional symptoms/internalizing problems, with third wave CBT yielding a large and significant effect compared to inactive controls but a small and non‐significant effect compared to active controls. As detailed in Table 3, analyses yielded some other interesting subgroup results (e.g. relating to participant age, type of third wave CBT, involvement of parents/carers in sessions, whether sessions were delivered in groups or to individuals, and whether studies were conducted in clinical or community settings); however, there were no clear patterns across variables and these analyses should be interpreted in context of moderation analyses remaining non‐significant as well as other limitations such as the small number of studies within selected subgroups.

TABLE 2.

Moderation and subgroup analyses for the primary outcome variables

k g a 95% CI p‐value Heterogeneity I 2 (Q with p‐value)
Emotional symptoms and internalizing problems
Intervention type (Qb = .98, p = .322)
ACT 28 −.63 −.95 to −.30 <.001 92% (330.60, <.001)
MBCT 11 −.93 −1.45 to −.42 <.001 90% (97.25, <.001)
Setting (Qb = .50, p = .480)
Clinical 15 −.79 −1.22 to −.35 <.001 87% (108.23, <.001)
Non‐clinical 28 −.59 −.90 to −.29 <.001 92% (326.13, <.001)
Control condition (Qb = 8.93, p = .003)
Active 19 −.27 −.61 to .07 .116 82% (99.26, <.001)
Inactive 24 −.96 −1.27 to −.66 <.001 90% (237.76, <.001)
Delivery (Qb = 1.37, p = .242)
Individual 13 −.41 −.88 to .06 .085 78% (53.42, <.001)
Group 28 −.75 −1.06 to −.44 <.001 93% (369.90, <.001)
Parental involvement (Qb = 2.75, p = .098)
Child‐only 29 −.80 −1.11 to −.50 <.001 93% (417.01, <.001)
Parents involved 14 −.35 −.79 to .10 .125 20% (16.19, .239)
Participant age (Qb = .18, p = .674)
Child 6 −.49 −1.13 to .15 .131 0% (4.14, .530)
Adolescent 22 −.65 −.98 to −.32 <.001 92% (270.80, <.001)
Behavioural difficulties and externalizing problems
Intervention type (Qb = 3.85, p = .050*)
ACT 14 −.38 −.81 to .04 .079 79% (61.33, <.001)
MBCT 7 −1.13 −1.74 to −.52 <.001 94% (103.71, <.001)
Setting (Qb = .01, p = .919)
Clinical 9 −.56 −1.06 to −.07 .027* 88% (67.28, <.001)
Non‐clinical 14 −.60 −.99 to −.20 .003 86% (95.18, <.001)
Control condition (Qb = .60, p = .438)
Active 9 −.44 −.89 to .02 .060 90% (80.67, <.001)
Inactive 14 −.67 −1.06 to −.29 <.001 79% (61.48, <.001)
Delivery (Qb = 1.13, p = .289)
Individual 4 −.18 −.94 to .58 .641 90% (31.57, <.001)
Group 17 −.64 −.99 to −.28 <.001 87% (127.37, <.001)
Parental involvement (Qb = 2.66, p = .103)
Child‐only 14 −.80 1.21 to −.39 <.001 91% (149.46, <.001)
Parents involved 9 −.27 −.76 to .23 .293 56% (18.02, .021)
Participant age (Qb = .47, p = .494)
Child 6 −.85 −1.43 to −.26 .004* 73% (18.32, .003)
Adolescent 10 −.59 −1.03 to −.15 .008* 86% (65.68, <.001)
Interference from difficulties
Intervention type
ACT
MBCT
Setting (Qb = 3.37, p = .066)
Clinical 8 −.88 −1.45 to −.31 .002 95% (134.69, <.001)
Non‐clinical 13 −.20 −.65 to .25 .376 83% (70.14, <.001)
Control condition (Qb = .49, p = .484)
Active 13 −.36 −.84 to .13 .151 94% (212.06, <.001)
Inactive 8 −.64 −1.27 to −.01 .048* 81% (36.76, <.001)
Delivery (Qb = 1.34, p = .247)
Individual 7 −.12 −.82 to .58 .733 28% (8.29, .218)
Group 14 −.62 −1.10 to −.14 .011* 95% (245.40, <.001)
Parental involvement (Qb = 1.94, p = .164)
Child‐only 12 −.24 −.72 to .25 .336 84% (67.04, <.001)
Parents involved 9 −.77 −1.34 to −.20 .008* 95% (158.56, <.001)
Participant age
Child
Adolescent
Third wave processes
Intervention type (Qb = .07, p = .785)
ACT 16 .38 .13 to .63 .003 78% (69.75, <.001)
MBCT 4 .46 −.02 to .93 .058 56% (6.80, .079)
Setting (Qb = .55, p = .457)
Clinical 5 .24 −.19 to .68 .275 79% (19.09, <.001)
Non‐clinical 17 .43 .20 to .66 <.001 73% (59.97, <.001)
Control condition (Qb = 2.39, p = .122)
Active 11 .25 −.00 to .50 .053 47% (18.87, .042)
Inactive 11 .55 .27 to .83 <.001 79% (47.40, <.001)
Delivery (Qb = .79, p = .373)
Individual 6 .22 −.20 to .64 .297 40% (8.33, .139)
Group 16 .44 .21 to .68 <.001 79% (70.09, <.001)
Parental involvement (Qb = .15, p = .695)
Child‐only 17 .41 .18 to .63 <.001 74% (60.88, <.001)
Parents involved 5 .31 −.15 to 76 .188 78% (18.32, .001)
Participant age
Child
Adolescent
Wellbeing and flourishing
ACT 15 .88 .47 to 1.30 <.001 90% (134.78, <.001)
MBCT 4 .47 −.33 to 1.28 .245 66% (8.95, .030)
Setting (Qb = .02, p = .899)
Clinical 7 .76 .18 to 1.34 .010* 85% (39.97, <.001)
Non‐clinical 14 .72 .31 to 1.12 <.001 87% (103.25, <001)
Control condition (Qb = 1.77, p = .183)
Active 8 .46 −.03 to .96 .065 82% (39.99, <.001)
Inactive 13 .90 .49 to 1.31 <.001 86% (86.91, <.001)
Delivery (Qb = 2.27, p = .132)
Individual 7 1.12 .52 to 1.73 <.001 91% (70.42, <.001)
Group 14 .56 .15 to .97 .008* 83% (75.47, <.001)
Parental involvement (Qb = 1.13, p = .288)
Child‐only 14 .86 .45 to 1.28 <.001 89% (121.26, <.001)
Parents involved 7 .48 −.09 to 1.05 .100 76% (25.02, <.001)
Participant age
Child
Adolescent
Quality of life
Intervention type
ACT
MBCT
Setting (Qb = 5.42, p = .020*)
Clinical 5 .98 .44 to 1.52 <.001 92% (48.20, <.001)
Non‐clinical 7 .15 −.28 to .59 .484 58% (14.28, .027)
Control condition (Qb = 5.06, p = .025*)
Active 5 .04 −.48 to .56 .885 0% (2.89, .576)
Inactive 7 .84 .37 to 1.31 <.001 90% (62.07, <.001)
Delivery (Qb = 1.48, p = .224)
Individual 5 .23 −.39 to .84 .470 46% (7.35, .118)
Group 7 .73 .20 to 1.26 .007* 92% (76.77, <.001)
Parental involvement (Qb = .30, p = .583)
Child‐only 7 .60 .08 to 1.11 .023* 91% (63.27, <.001)
Parents involved 5 .38 −.20 to .96 .198 76% (16.85, .002)
Participant age
Child
Adolescent
Physical health and pain
Intervention type
ACT
MBCT
Setting
Clinical
Non‐clinical
Control condition (Qb = .01, p = .918)
Active 5 .75 −.16 to 1.67 .105 97% (137.58, <.001)
Inactive 4 .68 −.36 to 1.72 .199 88% (25.67, <.001)
Delivery
Individual
Group
Parental involvement (Qb = .00, p = .957)
Child‐only 4 .70 −.27 to 1.67 .159 89% (27.80, <.001)
Parents involved 5 .73 −.13 to 1.60 .097 96% (109.03, <.001)
Participant age
Child
Adolescent

Where “−” is observed, moderation and subgroup analyses were not possible due to an insufficient number of studies (<4) per subgroup. Significant moderators and subgroups are denoted in bold.

Abbreviations: ACT, Acceptance and Commitment Therapy; CI, confidence interval; g, Hedges' g; I 2, percentage heterogeneity; k, number of studies in subgroup; MBCT, Mindfulness‐Based Cognitive Therapy; Qb, Qb‐statistic or level of variation explained by a covariate.

a

For emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, and interference from difficulties, a negative effect size favours the intervention group whilst a positive effect size favours the control comparison. For the remaining outcomes (third wave processes, wellbeing/flourishing, quality of life, and physical health/pain), a positive effect size favours the intervention group whilst a negative effect favours the control comparison.

*Whilst p < .05, this was non‐significant following correction using the Holm‐Bonferroni method.

TABLE 3.

Meta‐analyses of follow‐up data

k g a 95% CI p‐value Heterogeneity I 2 (Q with p‐value)
Emotional symptoms and internalizing problems (A = 8, I = 9)
Overall effect (N = 1680) 17 −.76 −1.32 to −.20 .008 96% (133.31, <.001)
Excluding low quality studies (N = 1242) 13 −.91 −1.64 to −.18 .014 97% (121.64, <.001)
Behavioural difficulties and externalizing problems (A = 6, I = 5)
Overall effect (N = 902) 11 −.83 −1.51 to −.15 .016 95% (106.52, <.001)
Excluding low quality studies (N = 789) 8 −.90 −1.88 to .07 .068 97% (88.86, <.001)
Interference from difficulties b (A = 6, I = 1)
Overall effect (N = 846) 7 −1.33 −2.85 to .19 .086 99% (281.54, <.001)
Third wave processes b (A = 4, I = 2)
Overall effect (N = 821) 6 .58 −.28 to 1.44 .188 97% (46.22, <.001)
Wellbeing and flourishing b (A = 5, I = 2)
Overall effect (N = 433) 7 .41 −.20 to 1.02 .188 87% (30.35, <.001)
Quality of life (A = 4, I = 1)
Overall effect (N = 642) 5 .14 −.01 to .30 .069 0% (1.41, .843)
Physical health and pain b (A = 5, I = 2)
Overall effect (N = 895) 7 .64 −.50 to 1.78 .269 98% (212.90, <.001)

Abbreviations: A, number of active controls in the main analysis for overall effect; CI, confidence interval; g, Hedges' g; I, number of inactive controls in the main analysis for overall effect; I 2, percentage heterogeneity; k, number of studies; N, participants included in analysis (based on intention‐to‐treat sample where available); Qb, Qb‐statistic or level of variation explained by a covariate.

a

For emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, and interference from difficulties, a negative effect size favours the intervention group whilst a positive effect size favours the control comparison. For the remaining outcomes (third wave processes, wellbeing/flourishing, quality of life, and physical health/pain), a positive effect size favours the intervention group whilst a negative effect favours the control comparison.

b

All studies at follow‐up were rated moderate‐high quality.

Significant effect sizes (p < .05) are denoted in bold.

Effects at follow‐up

Main effects at follow‐up are presented in Table 3. There were a relatively limited number of studies with follow‐up data, particularly for interference from difficulties, third wave processes, wellbeing/flourishing, quality of life, and physical health/pain. A significant overall effect favouring third wave CBT was observed for emotional symptoms/internalizing problems, which was moderate in size with all studies included and large with low quality studies excluded. For behavioural difficulties/externalizing problems, a large and significant effect was found with all studies included; however, this became non‐significant with low quality studies excluded. No significant effects were found for the other variables. There was significant heterogeneity for six of seven outcome variables.

Comparison to other psychological therapies

Eleven studies had a control group comprising a specific other psychological intervention, which were: conventional CBT (3), conventional CBT plus SSRI medication (1), conventional CBT (plus family therapy for one participant) (1); cognitive restructuring from conventional CBT (1), narrative exposure and response prevention (1), cognitive emotion regulation protocol (1), emotion regulation training (1), reality therapy based on choice theory (1) and the Stepping Stones Triple P Programme (1). For emotional symptoms/internalizing problems, there was a non‐significant, negligible difference to other psychological therapies (k = 10, g = −.17, 95% CI −.62 to .29, p = .472). For behavioural difficulties/externalizing problems, there was a small but non‐significant difference favouring third wave CBT (k = 6, g = −.48, 95% CI −1.14 to .19, p = .161). For interference from difficulties, there was a negligible, non‐significant difference between groups (k = 5, g = −.11, 95% CI −.34 to .11, p = .309). For wellbeing/flourishing, there was a small but non‐significant difference favouring third wave CBT (k = 6, g = .37, 95% CI −.12 to .86, p = .139). There were too few comparisons to explore the other outcome variables.

Further sensitivity analyses and publication bias

With studies using cluster randomization techniques excluded, results were comparable to main effects (Appendix S4). However, significant effects for wellbeing/flourishing and physical health/pain with all studies included were recategorized as large rather than moderate.

Rank correlation tests for funnel plot asymmetry were non‐significant for four of the seven primary outcomes; however, those which were significant included emotional difficulties/internalizing problems, behavioural difficulties/externalizing problems and well‐being/flourishing (Appendix S5). Nonetheless, visual analysis of funnel plots for these significant outcomes was not suggestive of bias and no missing studies were estimated. Whilst it was estimated that there were five missing null studies for interference from difficulties, asymmetry was non‐significant. See Appendix S4 for rank correlation tests and funnel plots.

DISCUSSION

Main findings

Fifty RCTs were included in this meta‐analysis. Main analyses yielded significant small‐moderate effects at post‐treatment in favour of third wave CBT compared to control conditions (both active/inactive) for measures of emotional symptoms/internalizing problems, behavioural difficulties/externalizing problems, interference from difficulties, third wave processes and wellbeing/flourishing, alongside non‐significant findings for quality of life. Nonetheless, a number of the identified studies were rated as low quality. It was decided a priori to consider the impact of study quality and other study characteristics, given the application of third wave CBT to child and adolescent populations is relatively novel and has been done with great variation. Sensitivity analyses excluding low quality studies changed results for some outcomes; behavioural difficulties/externalizing problems ceased to be significant whilst quality of life then yielded a small significant effect in favour of third wave CBT.

There were high levels of significant heterogeneity for all outcomes. Despite moderation analyses, this heterogeneity remained largely unexplained. Type of third wave CBT, setting, group versus individual delivery, parental involvement in therapy and participant age were not found to be significant moderators for any outcome. Type of control comparison (i.e. active versus inactive) was only a significant moderator for emotional symptoms/internalizing problems. Additional subgroup analyses yielded some interesting results however should be interpreted in context of moderation analyses remaining non‐significant. The reliability and validity of any significant moderators or apparent subgroup differences also needs to be carefully considered, given that low quality studies were included in these analyses; thus, effects may be explained by quality rather than the moderator or subgroup variable itself.

At follow‐up, moderate‐large significant superiority effects for third wave CBT were observed for emotional symptoms/internalizing problems and behavioural difficulties/externalizing problems. When low quality studies were excluded, the effect for behavioural difficulties/externalizing problems became non‐significant whilst the effect for emotional symptoms/internalizing problems remained significant and became large in size. For the remaining outcome variables, no significant effects were found at follow‐up, with or without low quality studies included. Nonetheless, given that only a minority of trials at post‐treatment included follow‐up assessments, it was difficult to evaluate maintenance effects. Power could have been limited, and there was a differing composition of studies for post‐intervention compared to follow‐up. For example, at follow‐up for interference from difficulties, third wave processes, quality of life, wellbeing/flourishing and physical health/pain, a greater proportion of studies utilized active control groups, relative to those studies that comprised post‐treatment comparisons. Another difference was that for these variables, many studies at follow‐up were conducted in clinical settings, whereas most studies at post‐treatment were conducted in non‐clinical settings. Analyses specifically comparing third wave to other psychological therapies at post‐treatment showed no significant differences.

Clinical and research implications

It is essential to ensure the quality of interventions offered within child and adolescent services, as well as investigate universal approaches that can be used more widely as preventative and promotive public health strategies for youth (DoH & DfE, 2017; PHE, 2019). Until now, no meta‐analysis existed to determine the effectiveness of these four types of third wave CBT as a transdiagnostic approach for young people, despite their arguable applicability across presentations, along the spectrum from ill‐health to flourishing, and subsequent popularity within clinical and non‐clinical settings. Overall, the present results suggest that third wave CBT is a promising intervention. Significant post‐treatment effects were found across a range of outcomes from symptomatology (such as emotional symptoms and internalizing problems) to thriving (such as outcomes capturing wellbeing, flourishing and quality of life). Sample size remained high for sensitivity analyses considering study quality, increasing confidence in the findings.

A significant effect was found for interference from difficulties. This pattern fits with the premise of third wave CBT, which often places more emphasis on facilitating change by altering a person's relationship with thoughts, emotions or difficulties (Hayes, 2004). Third wave processes also yielded significant effects, supporting change amongst underlying mechanisms of action targeted by these types of third wave CBT for children and adolescents. Quality‐controlled analyses suggested that third wave CBT may not be effective for behavioural difficulties/externalizing problems and physical health/pain. It is however important to note that there was considerable heterogeneity for both of these outcomes, with small‐moderate overall effect sizes favouring third wave CBT; this heterogeneity suggests that conclusions may not be generalizable and that further investigation is warranted.

Whilst comparisons were limited, findings suggested that third wave CBT did not perform significantly differently from other psychological therapies specifically, which included conventional CBT. At present, second wave CBT is viewed as the “gold standard” treatment in clinical guidelines (David et al., 2018). This review indicates that third wave interventions could be similarly effective, though this requires further research as only four of the seven primary outcomes could be compared to other psychological therapies and study numbers were limited. Cost‐effectiveness reporting and analyses are also essential in future research; the majority of included studies conducted relatively short, group interventions, suggesting the possibility that third wave CBT may be an inexpensive, clinically effective alternative to current treatments.

Maintenance effects were also difficult to evaluate as a relatively small number of studies included follow‐up data compared to post‐treatment. It is important to note that there was limited evidence that third wave CBT is effective for inducing long‐term change, except amongst the category of emotional symptoms/internalizing problems. Also promising was that despite being non‐significant, effect sizes were moderate‐large in favour of third wave CBT for behavioural difficulties/externalizing problems, interference from difficulties, third wave processes and quality of life. More high‐quality RCTs are needed to increase the scope and power of any future meta‐analyses assessing follow‐up effects. This is important to know whether such interventions are worth investing in to improve long‐term outcomes. Similarly, for earlier generations of CBT for children and adolescents, follow‐up effects are often not explored or are non‐significant (Battagliese et al., 2015; James et al., 2015; Uhre et al., 2020) and thus this could be a widespread issue for clinical consideration.

Despite the promising overall findings of this review, it is worth noting that widespread heterogeneity raised queries about generalizability, with moderation analyses offering limited explanation. Further high‐quality trials would also allow further investigation into potential moderator and subgroup effects which were preliminary explored in this review, with many planned analyses not being possible to conduct due to limited study numbers. When research is available, it is important to also explore moderator and subgroup analyses in conjunction as they may account for one another; for example, any differences between clinical and non‐clinical settings could be explained by mode of delivery in terms of group versus individual therapy. Similarly, there may be other important moderators to consider which were not included in this review, such as whether third wave CBT is used as a treatment, preventative, or promotive health intervention. There remains unexplained heterogeneity amongst findings from this analysis.

Strengths and limitations

This was a comprehensive review including a range of outcomes and a high number of participants across both clinical and non‐clinical settings. It enabled a thorough investigation into the effectiveness of specific types of third wave CBT for children and adolescents, from the treatment of symptomatology to promotion of thriving, as well as a rigorous evaluation of study quality. It is recognized that the wide variety of studies included means it is not possible to determine effectiveness for specific groups or situations; however, this review aimed to take a broad and exploratory stance into a relatively novel, transdiagnostic approach for supporting child and adolescent mental health and wellbeing.

It is important that future research gives due attention to quality considerations. For example, for 24 of the included studies, it was specified or assumed that data represented completer samples only. Analysing only a subset of those randomized can lead to overestimation of effect sizes, however. For example, because drop out may occur when participants find an intervention unhelpful or unacceptable (Gupta, 2011). This should be held in mind when interpreting results from this meta‐analysis, despite capturing use of intention‐to‐treat methods within quality ratings. Similarly, only 10 studies were rated as high quality overall, and only seven of these scored highly with regards to the specificity and quality of the intervention, making it further difficult to evaluate third wave CBT. Several papers used interventions that were unstandardized or otherwise limited (e.g. exploring only defusion from ACT). If high‐quality interventions were delivered, effects at post‐treatment and follow‐up may have differed.

It is important to note that an a priori power analysis was not undertaken. No meta‐analysis had been conducted to examine the four included types of third wave CBT for children and adolescents when this review began, and results from individual trials had been varied. Thus, expected effect sizes were unknown and informed power calculations would have been difficult. Regardless of how well powered a meta‐analysis is, such an approach is still the optimal strategy for synthesizing available literature, compared to other methods available (Valentine et al., 2010). Nonetheless, where between‐study variance is high, higher power is needed to detect effects. It should be recognized that power may have been limited for some analyses, particularly where study numbers were low (e.g. at follow‐up/within subgroup analyses).

A further limitation of this review was that, given there is no definitive list or agreement about which interventions constitute ‘third wave CBT’, decisions around which therapies were included and excluded will be open to question. It should be recognized that conclusions from this review are limited to only those therapies included. For example, dialectical behaviour therapy (Linehan, 1993) and schema therapy (Young, 1990) were amongst those excluded for their focus on axis I disorders, and mindfulness‐based stress reduction (Kabat‐Zinn, 1982) for its limited use of cognitive behavioural techniques beyond mindful meditation. In future research, it is important to explore other third wave interventions and compare them to those included in this review as well as earlier generations of therapy.

CONCLUSIONS

To our knowledge, this is the first meta‐analysis to consider the effectiveness of several types of third wave CBT as a transdiagnostic group of therapies for children and adolescents: specifically, ACT, CFT, MBCT and MCT for the scope of this review. Fifty RCTs were identified, though many were of poor quality, both with regards to research design and the intervention delivered. Results were promising; when low quality studies were excluded, significant effects were found for a variety of outcomes, including emotional symptoms/internalizing problems, interference from difficulties, third wave processes, well‐being/flourishing and quality of life. The results were non‐significant for behavioural difficulties/externalizing problems and physical health/pain. However, widespread heterogeneity remained for all variables, raising queries about the generalizability of findings. There was only significant evidence that third wave CBT is effective for inducing long‐term change for emotional symptoms/internalizing problems. Whilst further high‐quality research is warranted, including to explore heterogeneity and maintenance effects, this review indicates that third wave CBT could be a beneficial transdiagnostic approach to treatment, as well as a public health tool to promote thriving, amongst young people.

AUTHOR CONTRIBUTIONS

Samuel W. Spaul: Data curation; formal analysis; validation; writing – review and editing. Gemma Bowers: Conceptualization; methodology; supervision; validation; writing – review and editing. Abigail Perkins: Formal analysis; methodology; validation; writing – review and editing. Laura Pass: Formal analysis; methodology; supervision; validation; visualization; writing – review and editing.

FUNDING INFORMATION

The authors did not receive any specific funding or grants from any organization for the submitted work.

CONFLICT OF INTEREST

The authors have no relevant financial or non‐financial interests to disclose.

Supporting information

Appendix S1:

ACKNOWLEDGEMENTS

There are no acknowledgements to declare.

Perkins, A. M , Meiser‐Stedman, R. , Spaul, S. W. , Bowers, G. , Perkins, A. G. , & Pass, L. (2023). The effectiveness of third wave cognitive behavioural therapies for children and adolescents: A systematic review and meta‐analysis . British Journal of Clinical Psychology, 62, 209–227. 10.1111/bjc.12404

Contributor Information

Richard Meiser‐Stedman, Email: r.meiser-stedman@uea.ac.uk.

Laura Pass, Email: l.pass@uea.ac.uk.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

REFERENCES

  1. Battagliese, G. , Caccetta, M. , Luppino, O. I. , Baglioni, C. , Cardi, V. , Mancini, F. , & Buonanna, C. (2015). Cognitive‐Behavioural therapy for Externalising disorders: A meta‐analysis of treatment effectiveness. Behaviour Research and Therapy, 75, 60–71. 10.1016/j.brat.2015.10.008 [DOI] [PubMed] [Google Scholar]
  2. Brown, L. A. , Gaudiano, B. A. , & Miller, I. W. (2011). Investigating the similarities and differences between practitioners of second‐ and third‐wave cognitive Behavioural therapies. Behaviour Modification, 35(2), 187–200. 10.1177/0145445510393730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burckhardt, R. , Manicavasgar, V. , Batterham, P. J. , & Hadzi‐Pavlovic, D. (2016). A randomised controlled trial of strong minds: A school‐based mental health program combining acceptance and commitment therapy and positive psychology. Journal of School Psychology, 57, 41–52. 10.1016/j.jsp.2016.05.008 [DOI] [PubMed] [Google Scholar]
  4. David, D. , Cristea, I. , & Hofmann, S. G. (2018). Why cognitive behavioural therapy is the current gold standard of psychotherapy. Frontiers in Psychiatry, 9(4). 10.3389/fpsyt.2018.00004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Department of Health, & Department for Education . (2017). Transforming children and young people's mental health provision: A Green paper (Cm 9523). Crown Copyright. [Google Scholar]
  6. Eldridge, S. , Campbell, M. , Campbell, M. , Dahota, A. , Giraudeau, B. , Higgins, J. , Reeves, B. , & Seigfried, N. (2016). Revised Cochrane Risk of Bias Tool for Randomised Trials (RoB 2.0): Additional considerations for cluster‐randomised trials . https://sites.google.com/site/riskofbiastool/welcome/rob‐2‐0‐tool/archive‐rob‐2‐0‐cluster‐randomized‐trials‐2016
  7. Fritz, C. O. , Morris, P. E. , & Richler, J. J. (2012). Effect size estimates: Current use, calculations, and interpretations. Journal of Experimental Psychology: General, 141(1), 2–18. 10.1037/a0024338 [DOI] [PubMed] [Google Scholar]
  8. Gilbert, P. (2010). An introduction to compassion focused therapy in cognitive behaviour therapy. International Journal of Cognitive Therapy, 3, 97–112. 10.1521/ijct.2010.3.2.97 [DOI] [Google Scholar]
  9. Gupta, S. K. (2011). Intention‐to‐treat concept: A review. Perspectives in Clinical Research, 2(3), 109–112. 10.4103/2229-3485.83211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hamilton, K. W. , Aydin, B. , Mizumoto, A. , Coburn, K. , & Zelinksy, N. (2017). MAVIS: Meta‐Analysis via Shiny . R Package Version 1.1.3.
  11. Hayes, L. L. , & Ciarrochi, J. (2015). The thriving adolescent: Using acceptance and commitment therapy and positive psychology to help teens manage emotions, achieve goals and build connections. New Harbinger Publications. [Google Scholar]
  12. Hayes, S. C. (2004). Acceptance and commitment therapy, relational frame theory, and the third wave of Behavioural and cognitive therapies. Behaviour Therapy, 35, 639–665. 10.1016/S0005-7894(04)80013-3 [DOI] [PubMed] [Google Scholar]
  13. Hayes, S. C. , & Hofmann, S. G. (2017). The third wave of cognitive Behavioural therapy and the rise of process‐based care. World Psychiatry, 16(3), 245–246. 10.1002/wps.20442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hayes, S. C. , Strosahl, K. D. , & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential approach to behaviour change. Guilford Press. [Google Scholar]
  15. Hedges, L. V. (1981). Distribution theory for Glass's estimator of effect size and related estimators. Journal of Educational and Behavioural Statistics, 6(2), 107–128. 10.3102/10769986006002107 [DOI] [Google Scholar]
  16. Higgins, J. P. T. , & Green, S. (2011). Cochrane handbook for systematic reviews of interventions (Version 5.1.0). www.handbook.cochrane.org
  17. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6(2), 65–70. [Google Scholar]
  18. James, A. C. , James, G. , Cowdrey, F. A. , Soler, A. , & Choke, A. (2015). Cognitive Behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews. 10.1002/14651858.CD004690.pub4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kabat‐Zinn, J. (1982). An outpatient program in Behavioural medicine for chronic pain patients based on the practice of mindfulness meditation: Theoretical considerations and preliminary results. General Hospital Psychiatry, 4(1), 33–47. 10.1016/0163-8343(82)90026-3 [DOI] [PubMed] [Google Scholar]
  20. Kallesoe, K. H. , Schroder, A. , Jensen, J. S. , Wicksell, R. K. , & Rask, C. U. (2021). Group‐based acceptance and commitment therapy (AHEAD) for adolescents with multiple functional somatic syndromes: A randomized trial. JCPP Advances, 1(4), e12047. 10.1002/jcv2.12047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kashefinishabouri, J. , Saadi, Z. E. , Pasha, R. , Heidari, A. , & Makvandi, B. (2021). The effect of mindfulness‐based cognitive therapy and emotion‐regulation training on rumination and social anxiety in teenagers prone to addiction. Journal of Occupational Health and Epidemiology, 10(1), 1–11. 10.52547/johe.10.1.1 [DOI] [Google Scholar]
  22. Linehan, M. M. (1993). Cognitive‐Behavioural treatment of borderline personality disorder. Guilford Press. [Google Scholar]
  23. Makki, M. , Hill, J. F. , Bounds, D. T. , McCammon, S. , Mc Fall‐Johnsen, M. , & Delaney, K. R. (2018). Implementation of an ACT curriculum on an adolescent inpatient psychiatric unit: A quality improvement project. Journal of Child and Family Studies, 27, 2918–2924. 10.1007/s10826-018-1132-2 [DOI] [Google Scholar]
  24. National Institute for Health and Care Excellence (NICE) . (2012). Methods for the development of NICE public health guidance (Third Edition) . https://www.nice.org.uk/process/pmg4/resources/methods‐for‐the‐development‐of‐nice‐public‐health‐guidance‐third‐edition‐pdf‐2007967445701 [PubMed]
  25. Neff, K. , & Tirch, D. (2013). Self‐compassion and ACT. In Kashdan T. & Ciarrochi V. (Eds.), Mindfulness, acceptance, and positive psychology: The seven foundations of well‐being. New Harbinger Publications. [Google Scholar]
  26. O'Brien, K. M. , Larson, C. M. , & Murrell, A. R. (2008). Third‐wave behaviour therapy for children and adolescents: Progress, challenges, and future directions. In Greco L. & Hayes S. (Eds.), Acceptance and mindfulness treatments for children and adolescents: A Practitioner's guide (pp. 15–35). New Harbinger Publications. [Google Scholar]
  27. Pahnke, J. , Lundgren, T. , Hursti, T. , & Hirvikoski, T. (2014). Outcomes of an acceptance and commitment therapy‐based skills training Group for Students with high‐functioning autism Spectrum disorder: A quasi‐experimental pilot study. Autism, 18(8), 953–964. 10.1177/136236131501091 [DOI] [PubMed] [Google Scholar]
  28. Public Health England (PHE) . (2019). Universal approaches to improving children and Young People's mental health and wellbeing. Report of the findings of a special interest group. Crown Copyright. [Google Scholar]
  29. Segal, Z. V. , Williams, J. M. G. , & Teasdale, J. D. (2002). Mindfulness‐based cognitive therapy for depression: A new approach to preventing relapse. Guilford Press. [Google Scholar]
  30. Sterne, J. A. C. , Savovic, J. , Page, M. J. , Elbers, R. G. , Blencowe, N. S. , Boutron, I. , Cates, C. J. , Cheng, H.‐Y. , Corbett, M. S. , Eldridge, S. M. , Emberson, J. R. , Hernán, M. A. , Hopewell, S. , Hróbjartsson, A. , Junqueira, D. R. , Jüni, P. , Kirkham Toby Lasserson, J. J. , Li, T. , McAleenan, A. , … Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. British Medical Journal, 366, I4898. 10.1136/bmj.I4898 [DOI] [PubMed] [Google Scholar]
  31. Syeda, M. , & Andrews, J. W. (2021). Mindfulness‐based cognitive therapy as a targeted group intervention: Examining Children's changes in anxiety symptoms and mindfulness. Journal of Child and Family Studies, 30, 1002–1015. 10.1007/s10826-021-01924-4 [DOI] [Google Scholar]
  32. Thurstone, C. , Hull, M. , Timmerman, J. , & Emrick, C. (2017). Development of a motivational interviewing/acceptance and commitment therapy model for adolescent substance use treatment. Journal of Contextual Behavioural Science, 6, 375–379. 10.1016/j.jcbs.2017.08.005 [DOI] [Google Scholar]
  33. Twohig, M. P. , Petersen, J. M. , Fruge, J. , Ong, C. W. , Barney, J. L. , Krafft, J. , Lee, E. B. , & Lee, M. E. (2021). A pilot randomized controlled trial of online‐delivered ACT‐enhanced behavior therapy for trichotillomania in adolescents. Science Direct, 28, 653–668. 10.1016/j.cbpra.2021.01.004 [DOI] [Google Scholar]
  34. Uhre, C. F. , Uhre, V. F. , Lonfeldt, N. N. , Pretzmann, L. , Vangkilde, S. , Plessen, K. J. , Gluud, C. , Jakobsen, J. C. , & Pagsberg, A. K. (2020). Systematic review and meta‐analysis: Cognitive‐Behavioural therapy for obsessive‐compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 59(1), 64–77. 10.1016/j.jaac.2019.08.480 [DOI] [PubMed] [Google Scholar]
  35. Valentine, J. C. , Pigott, T. D. , & Rothstein, H. R. (2010). How many studies do you need? A primer on statistical power for meta‐analysis. Journal of Educational and Behavioral Statistics, 35(2), 215–247. 10.3102/1076998609346961 [DOI] [Google Scholar]
  36. Viechtbauer, W. (2010). Conducting meta‐analyses in R with the Metafor package. Journal of Statistical Software, 36(3), 1–48. 10.18637/jss.v036.i03 [DOI] [Google Scholar]
  37. Wells, A. (2009). Metacognitive therapy for anxiety and depression. The Guilford Press. [Google Scholar]
  38. White, K. , Lubans, D. R. , & Eather, N. (2022). Feasibility and preliminary efficacy of a school‐based health and well‐being program for adolescent girls. Pilot and Feasibility Studies, 8(15), 15. 10.1186/s40814-021-00964-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wicksell, R. K. , Melin, L. , Lekander, M. , & Olsson, G. L. (2009). Evaluating the effectiveness of exposure and acceptance strategies to improve functioning and quality of life in longstanding Paediatric pain – A randomised controlled trial. Pain, 141, 248–257. 10.1016/j.pain.2008.11.006 [DOI] [PubMed] [Google Scholar]
  40. Young, J. E. (1990). Schema‐focused cognitive therapy for personality disorders: A schema focused approach. Professional Resource Exchange. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix S1:

Data Availability Statement

The data that support the findings of this study are available from the corresponding authors upon reasonable request.


Articles from The British Journal of Clinical Psychology are provided here courtesy of Wiley

RESOURCES